Free Trial

CVRx (CVRX) Competitors

CVRx logo
$15.98 -0.83 (-4.94%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$15.98 0.00 (0.00%)
As of 01/31/2025 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVRX vs. INMD, BLFS, RXST, AORT, MDXG, LQDA, PLSE, EMBC, FNA, and ESTA

Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include InMode (INMD), BioLife Solutions (BLFS), RxSight (RXST), Artivion (AORT), MiMedx Group (MDXG), Liquidia (LQDA), Pulse Biosciences (PLSE), Embecta (EMBC), Paragon 28 (FNA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry.

CVRx vs.

CVRx (NASDAQ:CVRX) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, profitability, community ranking, dividends, earnings, analyst recommendations, valuation and risk.

CVRx currently has a consensus price target of $17.00, indicating a potential upside of 6.38%. InMode has a consensus price target of $22.40, indicating a potential upside of 30.16%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than CVRx.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CVRx
0 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.86
InMode
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, InMode had 5 more articles in the media than CVRx. MarketBeat recorded 7 mentions for InMode and 2 mentions for CVRx. CVRx's average media sentiment score of 1.34 beat InMode's score of 1.09 indicating that CVRx is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CVRx
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
InMode
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

InMode received 130 more outperform votes than CVRx when rated by MarketBeat users. Likewise, 73.85% of users gave InMode an outperform vote while only 72.09% of users gave CVRx an outperform vote.

CompanyUnderperformOutperform
CVRxOutperform Votes
31
72.09%
Underperform Votes
12
27.91%
InModeOutperform Votes
161
73.85%
Underperform Votes
57
26.15%

75.3% of CVRx shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 18.9% of CVRx shares are held by company insiders. Comparatively, 6.9% of InMode shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CVRx has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.12, suggesting that its stock price is 112% more volatile than the S&P 500.

InMode has a net margin of 36.26% compared to CVRx's net margin of -123.75%. InMode's return on equity of 21.46% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
CVRx-123.75% -89.06% -52.56%
InMode 36.26%21.46%19.19%

InMode has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CVRx$47.26M8.21-$41.20M-$2.70-5.92
InMode$492.05M2.94$197.92M$1.859.30

Summary

InMode beats CVRx on 12 of the 18 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CVRX vs. The Competition

MetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$387.74M$4.80B$5.57B$9.12B
Dividend YieldN/A51.39%5.31%3.99%
P/E Ratio-5.9225.9787.7617.96
Price / Sales8.2157.661,224.7575.80
Price / CashN/A52.1145.9637.70
Price / Book4.388.145.124.71
Net Income-$41.20M$89.07M$111.17M$224.24M
7 Day Performance-10.07%-2.28%2.38%-0.17%
1 Month Performance26.12%8.36%3.20%0.60%
1 Year Performance-36.08%29.54%24.70%20.43%

CVRx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CVRX
CVRx
1.2755 of 5 stars
$15.98
-4.9%
$17.00
+6.4%
-36.4%$408.84M$39.29M-5.92160
INMD
InMode
3.2296 of 5 stars
$17.09
-0.9%
$22.40
+31.1%
-27.4%$1.44B$492.05M9.24480
BLFS
BioLife Solutions
1.6268 of 5 stars
$28.28
+1.8%
$29.43
+4.1%
+60.6%$1.31B$143.27M-26.68440Short Interest ↑
RXST
RxSight
3.1741 of 5 stars
$32.50
+0.1%
$58.13
+78.8%
-25.6%$1.31B$128.29M-39.16220
AORT
Artivion
1.1884 of 5 stars
$30.62
-0.1%
$31.80
+3.8%
+85.2%$1.28B$384.90M-1,531.151,500Analyst Forecast
Positive News
MDXG
MiMedx Group
3.5633 of 5 stars
$8.71
-0.9%
$12.00
+37.8%
+12.4%$1.28B$321.48M15.84870News Coverage
High Trading Volume
LQDA
Liquidia
3.1662 of 5 stars
$14.01
-2.4%
$25.38
+81.1%
+11.3%$1.19B$17.49M-8.6050News Coverage
PLSE
Pulse Biosciences
1.839 of 5 stars
$18.66
+3.0%
N/A+135.7%$1.15B$700,000.000.00140Positive News
EMBC
Embecta
4.1206 of 5 stars
$19.40
+2.3%
$23.00
+18.6%
+4.6%$1.13B$1.12B14.372,100Upcoming Earnings
Short Interest ↑
FNA
Paragon 28
1.5302 of 5 stars
$11.66
+0.3%
$15.60
+33.8%
+2.7%$976.18M$216.39M-15.76343,000Analyst Forecast
Insider Trade
News Coverage
ESTA
Establishment Labs
2.8721 of 5 stars
$33.30
+1.3%
$60.60
+82.0%
-16.8%$932.46M$165.15M-12.91960Positive News

Related Companies and Tools


This page (NASDAQ:CVRX) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners